144 related articles for article (PubMed ID: 34837225)
1. COVID-19-specific metabolic imprint yields insights into multiorgan system perturbations.
Cornillet M; Strunz B; Rooyackers O; Ponzetta A; Chen P; Muvva JR; Akber M; Buggert M; Chambers BJ; Dzidic M; Filipovic I; Gorin JB; Gredmark-Russ S; Hertwig L; Klingström J; Kokkinou E; Kvedaraite E; Lourda M; Mjösberg J; Maucourant C; Norrby-Teglund A; Parrot T; Perez-Potti A; Rivera-Ballesteros O; Sandberg JK; Sandberg JT; Sekine T; Svensson M; Varnaite R; ; Eriksson LI; Aleman S; Strålin K; Ljunggren HG; Björkström NK
Eur J Immunol; 2022 Mar; 52(3):503-510. PubMed ID: 34837225
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics study of COVID-19 patients in four different clinical stages.
Valdés A; Moreno LO; Rello SR; Orduña A; Bernardo D; Cifuentes A
Sci Rep; 2022 Jan; 12(1):1650. PubMed ID: 35102215
[TBL] [Abstract][Full Text] [Related]
3. Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19.
Bi X; Liu W; Ding X; Liang S; Zheng Y; Zhu X; Quan S; Yi X; Xiang N; Du J; Lyu H; Yu D; Zhang C; Xu L; Ge W; Zhan X; He J; Xiong Z; Zhang S; Li Y; Xu P; Zhu G; Wang D; Zhu H; Chen S; Li J; Zhao H; Zhu Y; Liu H; Xu J; Shen B; Guo T
Cell Rep; 2022 Jan; 38(3):110271. PubMed ID: 35026155
[TBL] [Abstract][Full Text] [Related]
4. Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and Treatment.
Rendeiro AF; Vorkas CK; Krumsiek J; Singh HK; Kapadia SN; Cappelli LV; Cacciapuoti MT; Inghirami G; Elemento O; Salvatore M
Front Immunol; 2021; 12():809937. PubMed ID: 35095900
[TBL] [Abstract][Full Text] [Related]
5. Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications.
Xiao N; Nie M; Pang H; Wang B; Hu J; Meng X; Li K; Ran X; Long Q; Deng H; Chen N; Li S; Tang N; Huang A; Hu Z
Nat Commun; 2021 Mar; 12(1):1618. PubMed ID: 33712622
[TBL] [Abstract][Full Text] [Related]
6. Metabolic predictors of COVID-19 mortality and severity: a survival analysis.
Abdallah AM; Doudin A; Sulaiman TO; Jamil O; Arif R; Sada FA; Yassine HM; Elrayess MA; Elzouki AN; Emara MM; Thillaiappan NB; Cyprian FS
Front Immunol; 2024; 15():1353903. PubMed ID: 38799469
[TBL] [Abstract][Full Text] [Related]
7. Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19.
Cantwell AM; Singh H; Platt M; Yu Y; Lin YH; Ikeno Y; Hubbard G; Xiang Y; Gonzalez-Juarbe N; Dube PH
J Virol; 2021 Sep; 95(20):e0101021. PubMed ID: 34319784
[TBL] [Abstract][Full Text] [Related]
8. Amino Acid Metabolism is Significantly Altered at the Time of Admission in Hospital for Severe COVID-19 Patients: Findings from Longitudinal Targeted Metabolomics Analysis.
Ansone L; Briviba M; Silamikelis I; Terentjeva A; Perkons I; Birzniece L; Rovite V; Rozentale B; Viksna L; Kolesova O; Klavins K; Klovins J
Microbiol Spectr; 2021 Dec; 9(3):e0033821. PubMed ID: 34878333
[TBL] [Abstract][Full Text] [Related]
9. Progress in understanding COVID-19: insights from the omics approach.
Lin B; Liu J; Liu Y; Qin X
Crit Rev Clin Lab Sci; 2021 Jun; 58(4):242-252. PubMed ID: 33375876
[TBL] [Abstract][Full Text] [Related]
10. Integrative Modeling of Quantitative Plasma Lipoprotein, Metabolic, and Amino Acid Data Reveals a Multiorgan Pathological Signature of SARS-CoV-2 Infection.
Kimhofer T; Lodge S; Whiley L; Gray N; Loo RL; Lawler NG; Nitschke P; Bong SH; Morrison DL; Begum S; Richards T; Yeap BB; Smith C; Smith KGC; Holmes E; Nicholson JK
J Proteome Res; 2020 Nov; 19(11):4442-4454. PubMed ID: 32806897
[TBL] [Abstract][Full Text] [Related]
11. Multiomics: unraveling the panoramic landscapes of SARS-CoV-2 infection.
Wang X; Xu G; Liu X; Liu Y; Zhang S; Zhang Z
Cell Mol Immunol; 2021 Oct; 18(10):2313-2324. PubMed ID: 34471261
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Signatures Associated with Severity in Hospitalized COVID-19 Patients.
Marín-Corral J; Rodríguez-Morató J; Gomez-Gomez A; Pascual-Guardia S; Muñoz-Bermúdez R; Salazar-Degracia A; Pérez-Terán P; Restrepo MI; Khymenets O; Haro N; Masclans JR; Pozo OJ
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946479
[TBL] [Abstract][Full Text] [Related]
13. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.
Dewanjee S; Vallamkondu J; Kalra RS; Puvvada N; Kandimalla R; Reddy PH
Mol Neurobiol; 2021 Sep; 58(9):4694-4715. PubMed ID: 34169443
[TBL] [Abstract][Full Text] [Related]
14. Presentations and mechanisms of CNS disorders related to COVID-19.
Bodro M; Compta Y; Sánchez-Valle R
Neurol Neuroimmunol Neuroinflamm; 2021 Jan; 8(1):. PubMed ID: 33310765
[TBL] [Abstract][Full Text] [Related]
15. The COVIDome Explorer researcher portal.
Sullivan KD; Galbraith MD; Kinning KT; Bartsch KW; Levinsky NC; Araya P; Smith KP; Granrath RE; Shaw JR; Baxter RM; Jordan KR; Russell SA; Dzieciatkowska ME; Reisz JA; Gamboni F; Cendali FI; Ghosh T; Monte AA; Bennett TD; Miller MG; Hsieh EW; D'Alessandro A; Hansen KC; Espinosa JM
Cell Rep; 2021 Aug; 36(7):109527. PubMed ID: 34348131
[TBL] [Abstract][Full Text] [Related]
16. The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism.
Blasco H; Bessy C; Plantier L; Lefevre A; Piver E; Bernard L; Marlet J; Stefic K; Benz-de Bretagne I; Cannet P; Lumbu H; Morel T; Boulard P; Andres CR; Vourc'h P; Hérault O; Guillon A; Emond P
Sci Rep; 2020 Oct; 10(1):16824. PubMed ID: 33033346
[TBL] [Abstract][Full Text] [Related]
17. COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19.
Costanzo M; Caterino M; Fedele R; Cevenini A; Pontillo M; Barra L; Ruoppolo M
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269564
[TBL] [Abstract][Full Text] [Related]
18. Could metabolomics drive the fate of COVID-19 pandemic? A narrative review on lights and shadows.
Mussap M; Fanos V
Clin Chem Lab Med; 2021 Nov; 59(12):1891-1905. PubMed ID: 34332518
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions.
Adeniji OS; Giron LB; Purwar M; Zilberstein NF; Kulkarni AJ; Shaikh MW; Balk RA; Moy JN; Forsyth CB; Liu Q; Dweep H; Kossenkov A; Weiner DB; Keshavarzian A; Landay A; Abdel-Mohsen M
mBio; 2021 Apr; 12(2):. PubMed ID: 33879594
[TBL] [Abstract][Full Text] [Related]
20. Human bronchial-pulmonary proteomics in coronavirus disease 2019 (COVID-19) pandemic: applications and implications.
Tan HW; Xu YM; Lau ATY
Expert Rev Proteomics; 2021 Nov; 18(11):925-938. PubMed ID: 34812694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
